115 related articles for article (PubMed ID: 11956653)
1. Frequent polymorphism of peroxisome proliferator activated receptor gamma gene in colorectal cancer containing wild-type K-ras gene.
Tomita S; Kawamata H; Imura J; Omotehara F; Ueda Y; Fujimori T
Int J Mol Med; 2002 May; 9(5):485-8. PubMed ID: 11956653
[TBL] [Abstract][Full Text] [Related]
2. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
3. The PPAR{gamma} Pro12Ala polymorphism and risk for incident sporadic colorectal adenomas.
Gong Z; Xie D; Deng Z; Bostick RM; Muga SJ; Hurley TG; Hebert JR
Carcinogenesis; 2005 Mar; 26(3):579-85. PubMed ID: 15564289
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the peroxisome proliferator-activated receptor gamma gene in human malignancies.
Ikezoe T; Miller CW; Kawano S; Heaney A; Williamson EA; Hisatake J; Green E; Hofmann W; Taguchi H; Koeffler HP
Cancer Res; 2001 Jul; 61(13):5307-10. PubMed ID: 11431375
[TBL] [Abstract][Full Text] [Related]
5. Correlation of K-ras codon 12 mutations in human feces and ages of patients with colorectal cancer (CRC).
Chien CC; Chen SH; Liu CC; Lee CL; Yang RN; Yang SH; Huang CJ
Transl Res; 2007 Feb; 149(2):96-102. PubMed ID: 17240321
[TBL] [Abstract][Full Text] [Related]
6. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
8. Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver.
Schimanski CC; Linnemann U; Berger MR
Cancer Res; 1999 Oct; 59(20):5169-75. PubMed ID: 10537293
[TBL] [Abstract][Full Text] [Related]
9. [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].
Fu M; Chen H; Li X; Li J; Wu B; Cheng L; Cai M; Fu Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):234-8. PubMed ID: 12048686
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR
Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045
[TBL] [Abstract][Full Text] [Related]
11. K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy.
Etienne-Grimaldi MC; Formento JL; Francoual M; François E; Formento P; Renée N; Laurent-Puig P; Chazal M; Benchimol D; Delpero JR; Letoublon C; Pezet D; Seitz JF; Milano G
Clin Cancer Res; 2008 Aug; 14(15):4830-5. PubMed ID: 18676755
[TBL] [Abstract][Full Text] [Related]
12. The balanced induction of K-ras codon 12 and 13 mutations in mucosa differs from their ratio in neoplastic tissues.
Kraus MC; Seelig MH; Linnemann U; Berger MR
Int J Oncol; 2006 Oct; 29(4):957-64. PubMed ID: 16964391
[TBL] [Abstract][Full Text] [Related]
13. Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report.
Sameer AS; Chowdhri NA; Abdullah S; Shah ZA; Siddiqi MA
Indian J Cancer; 2009; 46(3):219-25. PubMed ID: 19574674
[TBL] [Abstract][Full Text] [Related]
14. Low somatic K-ras mutation frequency in colorectal cancer diagnosed under the age of 45 years.
Alsop K; Mead L; Smith LD; Royce SG; Tesoriero AA; Young JP; Haydon A; Grubb G; Giles GG; Jenkins MA; Hopper JL; Southey MC
Eur J Cancer; 2006 Jul; 42(10):1357-61. PubMed ID: 16765042
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism, Helicobacter pylori infection and non-cardia gastric carcinoma in Chinese.
Liao SY; Zeng ZR; Leung WK; Zhou SZ; Chen B; Sung JJ; Hu PJ
Aliment Pharmacol Ther; 2006 Jan; 23(2):289-94. PubMed ID: 16393309
[TBL] [Abstract][Full Text] [Related]
16. Ki-ras mutation modifies the protective effect of dietary monounsaturated fat and calcium on sporadic colorectal cancer.
Bautista D; Obrador A; Moreno V; Cabeza E; Canet R; Benito E; Bosch X; Costa J
Cancer Epidemiol Biomarkers Prev; 1997 Jan; 6(1):57-61. PubMed ID: 8993798
[TBL] [Abstract][Full Text] [Related]
17. K-ras mutational analysis of polyclonal colorectal cancers identifies uniclonal circulating tumor cells.
Thebo JS; Senagore AJ; Krygier S; Luchtefeld MA
Am Surg; 2001 Aug; 67(8):802-5. PubMed ID: 11510588
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive detection through REMS-PCR technique of K-ras mutations in stool DNA of patients with colorectal cancer.
Mixich F; Ioana M; Voinea F; Săftoiu A; Ciurea T
J Gastrointestin Liver Dis; 2007 Mar; 16(1):5-10. PubMed ID: 17410282
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
[TBL] [Abstract][Full Text] [Related]
20. Natural history of colorectal nonpolypoid adenomas: a prospective colonoscopic study and relation with cell kinetics and K-ras mutations.
Watari J; Saitoh Y; Obara T; Fujiya M; Maemoto A; Ayabe T; Ashida T; Yokota K; Orii Y; Kohgo Y
Am J Gastroenterol; 2002 Aug; 97(8):2109-15. PubMed ID: 12190185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]